Related Experiment Video
Updated: Jun 22, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Serial changes in oxidized low-density lipoprotein associated with culprit vessel in ST-elevation myocardial
Patrícia Napoleão1, Mafalda Selas, Alexandra Toste
1Centro de Biologia Ambiental, Universidade de Lisboa, Lisboa, Portugal. pnapoleao@itn.pt
Insights
Oxidized LDL (oxLDL) is elevated in acute myocardial infarction (AMI) patients, decreasing during recovery. Higher oxLDL correlates with more severe coronary artery disease, suggesting its potential as an AMI marker.
Area of Science:
- Cardiology
- Biochemistry
- Biomarker Discovery
Background:
- Oxidized low-density lipoprotein (oxLDL) plays a role in atherosclerosis.
- Acute myocardial infarction (AMI) is a critical cardiovascular event.
- Understanding biomarkers for AMI progression is crucial.
Purpose of the Study:
- To investigate oxLDL variations in AMI patients during acute and recovery phases.
- To explore the relationship between oxLDL levels and coronary artery disease severity.
- To assess oxLDL as a potential marker for AMI evolution.
Main Methods:
- Plasma oxLDL concentrations were measured using ELISA.
- A cohort of 50 AMI patients and 25 healthy controls were studied.
- AMI patients were assessed at admission, and 2 and 40 days post-intervention.
Main Results:
- oxLDL levels were significantly higher in AMI patients during the acute phase compared to controls.
- oxLDL concentrations decreased progressively during the recovery period.
- Lower oxLDL levels were observed in patients with left circumflex artery (LCX) lesions compared to left anterior descending (LAD) or right coronary artery (RCA) lesions.
Conclusions:
- Elevated oxLDL is associated with AMI and correlates with coronary artery disease severity.
- oxLDL levels decrease during recovery from AMI.
- oxLDL shows promise as a biomarker for assessing AMI progression and prognosis.
Abstract:
The aim of the present study was to investigate variations in oxidized LDL (oxLDL) at the onset of acute myocardial infarction (AMI) and over the recovery period, exploring their relationship with coronary disease severity. A follow-up of 50 AMI patients was evaluated against 25 healthy volunteers (reference group). The AMI patients were evaluated at three time points: at admission before the administration of IIb/IIIa inhibitors and angioplasty, and two and 40 days after intervention. Plasma oxLDL concentrations were measured by ELISA. oxLDL was found to be significantly higher in AMI patients in the acute phase relative to reference levels, decreasing progressively over the recovery period. The results also demonstrated that oxLDL levels were decreased in patients with the left circumflex artery (LCX) as culprit vessel compared to the left anterior descending coronary (LAD) or right coronary artery (RCA). The results highlight a significant increase in oxLDL concentration related to coronary artery disease severity, as conditions such as LCX lesions are usually associated with a favorable prognosis, contrasting with LAD-associated conditions that can compromise large areas of myocardium. The results thus suggest that oxLDL may constitute a promising marker in assessment of AMI evolution.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Inflammation
Coronary Artery Disease I: Introduction